The DOI matches its Crossref record; 103 of the 105 references it cites were found in a registry or an index.
Cardiac troponins: from myocardial infarction to chronic disease
Open accessAbstract
Elucidation of the physiologically distinct subunits of troponin in 1973 greatly facilitated our understanding of cardiac contraction. Although troponins are expressed in both skeletal and cardiac muscle, there are isoforms of troponin I/T expressed selectively in the heart. By exploiting cardiac-restricted epitopes within these proteins, one of the most successful diagnostic tests to date has been developed: cardiac troponin (cTn) assays. For the past decade, cTn has been regarded as the gold-standard marker for acute myocardial necrosis: the pathological hallmark of acute myocardial infarction (AMI). Whilst cTn is the cornerstone for ruling-out AMI in patients presenting with a suspected acute coronary syndrome (ACS), elevated cTn is frequently observed in those without clinical signs indicative of AMI, often reflecting myocardial injury of 'unknown origin'. cTn is commonly elevated in acute non-ACS conditions, as well as in chronic diseases. It is unclear why these elevations occur; yet they cannot be ignored as cTn levels in chronically unwell patients are directly correlated to prognosis. Paradoxically, improvements in assay sensitivity have meant more differential diagnoses have to be considered due to decreased specificity, since cTn is now more easily detected in these non-ACS conditions. It is important to be aware cTn is highly specific for myocardial injury, which could be attributable to a myriad of underlying causes, emphasizing the notion that cTn is an organ-specific, not disease-specific biomarker. Furthermore, the ability to detect increased cTn using high-sensitivity assays following extreme exercise is disconcerting. It has been suggested troponin release can occur without cardiomyocyte necrosis, contradicting conventional dogma, emphasizing a need to understand the mechanisms of such release. This review discusses basic troponin biology, the physiology behind its detection in serum, its use in the diagnosis of AMI, and some key concepts and experimental evidence as to why cTn can be elevated in chronic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardiac troponin I (cTnI) is a gold-standard biomarker for cardiovascular diseases (the leading cause of death worldwide)22–25.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [25]
In the citing paper
“Note that the estimated levels of cTnI released after cardiac injury events such as AMI are typically in the range of 0.5–50 ng/mL25,27.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Third universal definition of myocardial infarction
the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., CHAITMAN, B. R., & White, H. D. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.122 · Cited by 6,585
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Third universal definition of myocardial infarction
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Thygesen, K., Alpert, J. S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs184 · Cited by 3,095
Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & de Werf, F. V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,014
Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Apple, F. S., Collinson, P. O., & for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165795 · Cited by 861
Self-citationBlebs lead the way: how to migrate without lamellipodia
Charras, G., & Paluch, E. K. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2453 · Cited by 822
Flagged first, then by citations
2 of the 105 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Bernard, 1979, Nomenclature and criteria for diagnosis of ischaemic heart disease, Circulation, 59, 607
- Vasile, 2009, The biological basis of troponin in heart disease: possible uses for troponin fragmentology, Heart Metab, 43, 5
Cited by
Sorted by citations
Items 401–500 of 509
Guan, X., Tian, L., Fan, J., Yang, W., Wu, D., & Li, X. (2022) · PubMed Central · Cited by 1
Cathepsin causal association with pulmonary embolism: a Mendelian randomization analysisPreprint
Deng, W., & Gao, W. (2024) · Research Square · doi:10.21203/rs.3.rs-4191858/v1 · Cited by 1
PENINGKATAN HIGH-SENSITIVE CARDIAC TROPONIN (HS-CTN) SETELAH LATIHAN INTENSITAS TINGGI YANG INTENSIF
Juhanna, I. V., Wahyuni, N., & Griadhi, I. P. A. (2019) · Sport and Fitness Journal · doi:10.24843/spj.2018.v06.i03.p05
The Clinical Utility of Salivary Galectin-3 in Heart Failure
Arachchilage, N. T. K. W. (2019) · Queensland University of Technology · doi:10.5204/thesis.eprints.130826
ŠIUOLAIKINIS POŽIŪRIS Į DIDELIO JAUTRUMO TROPONINO KONCENTRACIJOS PADIDĖJIMĄ
Juknevičienė, R., Matuliauskaitė, L., Juknevičius, V., & Šerpytis, P. (2019) · Health Sciences · doi:10.35988/sm-hs.2019.061
Highly Sensitive Cardiac Troponin T Changes and Its Prognostic Value in Patients with Acute Stroke
Doha, N. M., Melake, M. S., Elkersh, A., & Badr, M. H. (2020) · doi:10.35248/2155-6148.20.11.936
Borzyszkowska, A., Mickiewicz, A., Pisowodzka, I., Gruchała, M., & Fijałkowski, M. (2020) · Folia Cardiologica · doi:10.5603/fc.a2020.0017
Omoto, A. C. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-21022020-155407
Role of Monocyte Chemoattractant Protein-1 for Diagnosing Acute Myocardial Infarction
Omran, M. M., Zahran, F. M., Kadry, M., Belal, A. A. M., & Reihan, M. S. (2019) · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research · doi:10.21608/jbaar.2019.105887
Alcalai, R., Varshisky, B., Marhig, A., Leibowitz, D. W., Boguslavsky, L., Dorfman, E., Steiner, D., Katz, E., Salameh, S., & Lotan, C. (2020) · Cardiology · doi:10.1159/000511435
Zhang, G., He, C., Liu, Z., Pan, S., He, T., Zhao, X.-J., & Zhang, X. (2020) · Research Square · doi:10.21203/rs.3.rs-124309/v1
Teaching an Old Dog New Tricks: Serum Troponin T as a Biomarker in Amyotrophic Lateral SclerosisPreprint
Castro‐Gomez, S., Radermacher, B., Tacik, P. M., Mirandola, S. R., Heneka, M. T., & Weydt, P. (2021) · medRxiv · doi:10.1101/2021.02.15.21251783
Predicting adverse outcomes in older medical emergency department patients
Zelis, N. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201216nz
Kadry, M., Zahran, F. M., Emran, T. M., & Omran, M. M. (2021) · The Open Biochemistry Journal · doi:10.2174/1874091x02115010020
Disease Hazards and Immune Responses of Wistar Albino Rat Infected with Streptococcus Mutans
Abumourad, I. M. K. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.32.005267
Draghici, A., Buzea, A., Delcea, C., Vîjan, A. E., & Dan, G. A. (2021) · Revista română de medicină de laborator · doi:10.2478/rrlm-2021-0015
Evaluating The Activity Of Paraoxonase 1 In Myocardial Infarction
SABER, S., & abbas, L. (2021) · Mağallaẗ al-Mawṣil li-l-tamrīḍ/Mosul journal of nursing · doi:10.33899/mjn.2021.168081
FEDOROVA, T. A., Tazina, S. Y., Семененко, Н. А., Mamonov, A. V., & Sotnikova, T. I. (2019) · PERIÓDICO TCHÊ QUÍMICA · doi:10.52571/ptq.v16.n32.2019.455_periodico32_pgs_437_454.pdf
Chen, L., Zhong, Y., Xu, Y., Chen, L., & Yu, F. (2021) · International Journal of Heart Rhythm · doi:10.4103/ijhr.ijhr_14_21
Feger, J., Sharma, R., & Sheikh, Y. (2020) · Radiopaedia.org · doi:10.53347/rid-80167
Therapeutic Strategies in Patients with Postoperative Elevation of Cardiac Biomarkers
Yurttas, T., Wanner, P. M., & Filipovic, M. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87302-8_6-1
SOLIMAN, C., Agwa, S. H. A., Fathy, S. A., Emam, M. A., Elshazly, A., & Ibrahim, D. M. (2022) · Turkiye Klinikleri Cardiovascular Sciences · doi:10.5336/cardiosci.2022-90615
Detection of Myocardial Injury After Noncardiac Surgery: Levelling the Troponin Playing Field
Gouda, P., & Graham, M. M. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.01.007
Therapeutic Strategies in Patients with Postoperative Elevation of Cardiac Biomarkers
Yurttas, T., Wanner, P. M., & Filipovic, M. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07395-3_6
Motawei, S. M. (2022) · Open Access Journal of Toxicology · doi:10.19080/oajt.2022.05.555663
Onyedikachi, U. B., Egbuonu, A. C. C., Awah, F. M., Ijioma, S. N., & Nkpaa, K. W. (2023) · Research Square · doi:10.21203/rs.3.rs-2847266/v1
breakthrough in acute coronary syndrome diagnostics – transdermal troponin assessment
Rejmer, A., SZALA-CZERWONKA, K., WOŚ, N., ROJEK, K., BEDNARZ, L., WIJAS, K., Bialic, K., Bakalarczyk, R., BIALIC, A., & Majewski, P. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.24.01.006
Abdulsattar, S. A., & Ali, D. H. (2023) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2023.v7.i1a.167
Gaze, D. C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111799
Self-citationChapman, E. A., Roberts, D. S., Tiambeng, T. N., Andrews, J., Wang, M., Reasoner, E. A., Melby, J. A., Li, B. H., Kim, D., Alpert, A. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.13.544817
Nanoproteomics: An Approach for the Identification of Molecular Targets Associated with Hypoxia
Priya, J. D. A., Malik, S., Khalid, M., & Gautam, A. (2023) · Smart nanomaterials technology · doi:10.1007/978-981-99-1718-1_8
Saúde Digital e Desenvolvimento Humano: tecnologias e metodologias ativas em pesquisa
Moreira, J. N., Nascimento, M. E., Santos, V. M. S. D., Souza, N. N. D., Peruzzo, M. P., De Siqueira Junior, E. F., Da Silva Júnior, G. C., Leopoldo Claudino Da Silva, R. D. K., Soares, A. P., Mielczarski Martins, R., et al. (2023) · Editora Científica Digital eBooks · doi:10.37885/978-65-5360-443-8
PRINCIPAIS BIOMARCARDORES UTILIZADOS EM REABILITAÇÃO CARDÍACA
Vaz, J. A., Pereira, A. J. B. C., & Mendes, E. (2023) · Editora Científica Digital eBooks · doi:10.37885/230713749
HUBUNGAN JUMLAH SEL NEUTROFIL DENGAN KADAR TROPONIN I PADA PENDERITA INFARK MIOKARD AKUT
Hikma, C. T., Handayati, A., & Sulami, E. A. S. (2022) · Analis Kesehatan Sains · doi:10.36568/anakes.v10i2.20
Koch, P. F., García‐Hidalgo, M. C., Labus, J., Biener, M., Thum, T., de Gonzalo‐Calvo, D., & Bär, C. (2024) · medRxiv · doi:10.1101/2024.01.30.24302038
Chen, H., Li, C., Shao, C., Wu, Y., Wan, H., & He, Y. (2024) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3492
Kawsar, S. M. (2024) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v12i03.03
Bhaskaran, M. C., Chidambaram, P., Sakeeba, S. S., Eswaramoorthy, N., Bagherjeri, F. A., Monhemi, H., Perera, G. S., & Sriram, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4780968
Ameliorating the Cardiovascular Disorders after Ovariectomy By Alpha Lipoic Acid Supplementation
Rwayyih, H. S., & AL-Azawi, T. S. S. (2024) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2024/12.6.1041.1046
Capacidad pronóstica de troponina I de alta sensibilidad: mortalidad y rehospitalización
Saavedra-González, Y. A., Giraldo, S., Muñoz, E., Gándara-Ricardo, J. A., Cárdenas, J. P., Correa, G., Bettin, A., Villegas, J. E. C., Buitrago, C. C., Navarro, A., et al. (2024) · Revista Peruana de Cardiología · doi:10.24875/rperc.24000006
High-sensitivity troponin I in patients with arterial hypertension
Pereverzeva, K. G., Nizov, A. A., Bark, S. D., & Sherbakova, O. N. (2024) · Cardiosomatics · doi:10.17816/cs628206
COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies
Li, P., Chen, Q., Jovin, I. S., Mankad, A. K., Huizar, J. F., Markley, J. D., Bart, B. A., Hattler, B. G. J., Lesnefsky, E. J., & McFalls, E. O. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100473
The value of troponin measurement in carotid revascularization: are we making the most of it?
Jovanović, K., Trailović, R., Jovanovic, M. D., & KONCAR, I. B. (2024) · Italian Journal of Vascular and Endovascular Surgery · doi:10.23736/s1824-4777.24.01675-9
Impact of High Troponin Level on the Outcome in COVID-19 Positive Patients
Abohamr, S. I., Kattea, M., Abazid, R. M., Aldossari, M. A., Asiri, N. A., Alhussini, A. U., AlHussaini, K. I., Alasiri, G. A., Ali, A., & Elsheikh, E. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s489622
Interprétation d’une valeur élevée de troponine en dehors des syndromes coronariens aigus
Carpentier, M., & Bigot‐Corbel, E. (2024) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(24)00357-5
Electrochemically Synthesized MIPs for Sensor Applications in Healthcare Diagnostics
Ayankojo, A. G., Reut, J., & Syritski, V. (2024) · Springer series on polymer and composite materials · doi:10.1007/978-3-031-67368-9_6
Biochemical Markers of Acute Coronary Syndromes
Liu, L., & Cao, J. (2024) · Encyclopedia of Analytical Chemistry · doi:10.1002/9780470027318.a0507.pub2
Potential Cardioprotective effect of Trimetazidine in Mice model of endotoxemia: role of AMPK-Nrf2
Mosa, A. K., Majeed, S., Ghafil, F. A., & Hadi, N. R. (2025) · Wiadomości Lekarskie · doi:10.36740/wlek/190820
Defining Chronic Myocyte Injury With hs-cTnT
Miller, G., Davies, S. L., Hatherley, J. D., Lambert, A., Fearon, H., Bailey, L. M., Collinson, P. O., & Khand, A. U. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.103631
Self-citationCharles, N., Nemeyimana, P., Fabrice, U., Emmanuel, T., Yvette, U., Nshimiyimana, T., Valens, K., Alain, I., Benon, T., Eliah, S., et al. (2025) · doi:10.56147/jidpc.2.1.7
Mashhadian, A. A., Nayeri, H., & Sichani, Z. R. (2025) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.025.33007 · Cited by 1
Neetu, K. M., Kumar, S., Garg, A., & Fatma, N. (2025) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2025.00027
Matsuo, K., Arai, T., Nagai, M., Hori, Y., Hoya, H., Gatate, Y., Yoshitake, A., & Nakano, S. (2025) · CJC Open · doi:10.1016/j.cjco.2025.08.011
Cardiovascular Toxicity in Diabetes Mellitus: Focus on Diabetogenic and Anti-diabetogenic Agents
Radisavljevic, N. M., Mutavdžin, S., & Djuric, D. M. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_9
Lateral flow assays for cancer biomarkers
Malode, S. J., & Shetti, N. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23883-3.00012-x
Qureshi, M. A., Cook, B. C., Brennan, B., Miller, J. B., & McCord, J. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02789-z
Wang, Y., Chen, J., Jiang, H., & Li, X. (2025) · Physiological Research · doi:10.33549/physiolres.935530
Okura, Y., Bamba, T., Kawasaki, T., Asatani, M., Aoki, M., Nakagawa, S., Takenouchi, T., Tanaka, H., & Inomata, T. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.106488
Saczek, J., Dann, A., Crapnell, R. D., Banks, C. E., Johnson, R., Canfarotta, F., Thomson, A., Zaman, A., Spyridopoulos, I., Novakovic, K., et al. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00441a
Samuel, N. A., Roddick, A., Glampson, B., Mulla, A., Davies, J., Papadimitriou, D., Panoulas, V., Mayer, E., Woods, K., Shah, A. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26743871
Ansund, J., Mijwel, S., Bolam, K. A., Altena, R., Wengström, Y., Rullman, E., & Rundqvist, H. (2021) · Figshare · doi:10.6084/m9.figshare.14037709
Samuel, N. A., Roddick, A., Glampson, B., Mulla, A., Davies, J., Papadimitriou, D., Panoulas, V., Mayer, E., Woods, K., Shah, A. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26743865
Thonusin, C., Osataphan, N., Leemasawat, K., Nawara, W., Sriwichaiin, S., Supakham, S., Gunaparn, S., Apaijai, N., Somwangprasert, A., Phrommintikul, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720101
Samuel, N. A., Roddick, A., Glampson, B., Mulla, A., Davies, J., Papadimitriou, D., Panoulas, V., Mayer, E., Woods, K., Shah, A. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26743859
Xie, J., Liao, W., Chen, W., Lai, D., Tang, Q., & Li, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19311905
Ansund, J., Mijwel, S., Bolam, K. A., Altena, R., Wengström, Y., Rullman, E., & Rundqvist, H. (2021) · Figshare · doi:10.6084/m9.figshare.14037712
Różycka-Kosmalska, M., Frankowski, R., Grabarczyk, M., Sipowicz, K., Pękala‐Wojciechowska, A., Pietras, T., Opielak, G., & Kosmalski, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041455
Conserved RNA–protein modules link early anthracycline responses to atrial fibrillation riskPreprint
Johnson, O. D., Matthews, E. R., Paul, S., Gutiérrez, J. A., Russell, W. K., & Ward, M. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.15.706019
Denessen, E. J. S., Swinnen, B., Lamers, S. K., Delnoij, T., van Doorn, W. P. T. M., Bekers, O., Segers, P., Maessen, J. G., van der Horst, I. C. C., Heuts, S., et al. (2026) · Clinical Chemistry · doi:10.1093/clinchem/hvag012
Investigating emerging biomarkers for evaluating cardiac insufficiency
Chowdhury, D., Das, A., Mishra, A., Bano, F., Ghosh, A., Manna, R., Ghosh, S., & Bodakhe, S. H. (2026) · Next research. · doi:10.1016/j.nexres.2026.101534
Garofalo, M., Panichella, G., & Aimo, A. (2026) · Advances in clinical chemistry · doi:10.1016/bs.acc.2026.03.005
Formation of a SERS-Active Silver Nanorod Array Based on a Porous Anodic Alumina Template
Novikov, D. V., Прудникова, М. Ю., Strukova, E. I., Владимирович, Д. С., Nazarkina, Y., & Павлович, С. Т. (2026) · Bulletin of the Russian Academy of Sciences Physics · doi:10.1134/s1062873825715156
Guo, J., Wu, Q., Jiang, F., Cai, M., Xie, L., Xie, Y., Lin, X., Chen, X., Luo, S., Dai, X., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08116-y
Li, B.-Y., Li, X.-Q., Jiang, Y.-T., Li, X.-Y., Tian, Z., & Kang, R. (2026) · iScience · doi:10.1016/j.isci.2026.115742
Zhu, Z., Zhang, Y., Fang, Z., Li, X., Ma, C., Liu, Q., Zhang, Q., Zhu, W., Su, H., & Xu, X. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-03951-y
The Menopausal Transition and Cardiovascular Aging
Wang, Z., & Khoudary, S. R. E. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.04.003
Młynarska, E., Bojdo, K., Mazur, O., Pawlak, K., Przybylak, A., Kustosik, N., Krawiranda, K., Rysz, J., & Franczyk, B. (2026) · Biomedicines · doi:10.3390/biomedicines14061301
Serum cytokine panel predicts cardiac outcomes following acute myocardial infarction
Tai, S. (2026) · Journal of Medical Biochemistry · doi:10.5937/jomb0-64892
Tan, R., Wang, L., Wang, R., Tao, T., Xia, X., Wang, P., He, H., & Chang, G. (2026) · Microchimica Acta · doi:10.1007/s00604-026-08273-3
Spatially resolved single-cell atlas reveals the macroevolutionary trajectory of animal hearts
Lian, S., Wang, W., Liu, Y., Lu, M., Han, W., Luo, J., Zhang, X., Pang, Y., Li, Y., Li, Y., et al. (2026) · Science · doi:10.1126/science.adw0855
Metadata
- Authors
- Park, K. C., Gaze, D. C., Collinson, P. O., & Marber, M. S.
- Affiliations
- King's College London (GB)
- St George's, University of London (GB)
- Corresponding author
- Marber, Michael S
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-14
- Volume
- 113
- Issue
- 14
- Pages
- 1708-1718
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC5852618
- OpenAlex
- W2755269296
- Cited by
- 510
- References
- 105
- Citations by year
- 2026: 41 · 2025: 59 · 2024: 80 · 2023: 53 · 2022: 70 · 2021: 74 · 2020: 70 · 2019: 49 · 2018: 12 · 2017: 2
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cardiovascular Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
- Funders
- Medical Research Council (G1000737)
- British Heart Foundation (TG/15/1/31518 and FS/15/13/31320)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Takotsubo Cardiomyopathy and Associated Phenomena
- Keywords
- cardiac troponin, troponin I, troponin T, acute myocardial infarction, acute coronary syndrome, myocardial injury, high-sensitivity troponin assays, chronic disease, cardiac contraction
- MeSH terms
- Animals, Chronic Disease, Humans, Myocardial Infarction, Myocardium, Biomarkers, Troponin T, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review